Most small-molecule inhibitors of voltage-gated ion channels display poor subtype specificity because they bind to highly conserved residues located in the channel’s central cavity. Using a combined ...
NEW HAVEN, Conn., Feb. 25, 2022 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN; the "Company" or "Biohaven") announced today that it has entered into a definitive agreement ...
Findings highlight the advantages of Adolore’s approach for the delivery of proprietary gene therapy directly to specialized pain-sensing peripheral nerves (nociceptors) that mediates profound ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 22 (Jun. 3, 2008), pp. 7869-7874 (6 pages) Members of the Kv7 family (Kv7.2-Kv7.5) generate a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--QurAlis Corporation, a biotech company developing breakthrough precision medicines for ALS and other genetically validated neurodegenerative diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback